GF Fund Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$68.3K Hold
2025
Q1
$79.7K Buy
2024
Q4
$99.5K Buy